Feasibility of high-dose paclitaxel in the conditioning regimen for autologous hematopoietic transplantation.

被引:0
|
作者
Perez-Calvo, J
Fernández-Hidalgo, O
Aramendía, JM
Rebollo, J
Salgado, E
Rifón, JJ
Prósper, F
Rocha, E
Martín-Algarra, S
机构
[1] Univ Navarra Clin, Pamplona, Spain
[2] Clin San Miguel, Pamplona, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5453
引用
收藏
页码:431B / 431B
页数:1
相关论文
共 50 条
  • [1] Feasibility of high-dose paclitaxel in the conditioning regimen for autologous haematopoietic transplantation
    Perez-Calvo, J
    Fernandez-Hidalgo, O
    Aramendia, JM
    Salgado, E
    Lopez-Picazo, JM
    Rebollo, J
    Rifon, J
    Prosper, F
    Rocha, E
    Martin-Algarra, S
    BONE MARROW TRANSPLANTATION, 2004, 33 : S39 - S40
  • [2] Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation
    Chen, Yi-Bin
    Lane, Andrew A.
    Logan, Brent R.
    Zhu, Xiaochun
    Akpek, Goerguen
    Aljurf, Mahmoud. D.
    Artz, Andrew S.
    Bredeson, Christopher N.
    Cooke, Kenneth R.
    Ho, Vincent T.
    Lazarus, Hillard M.
    Olsson, Richard F.
    Saber, Wael
    McCarthy, Philip L.
    Pasquini, Marcelo C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (06) : 1046 - 1053
  • [3] Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation (AutoHCT)
    Lane, Andrew A.
    Chen, Yi-Bin
    Logan, Brent R.
    Akpek, Goergun
    Zhu, Xiaochun
    Lazarus, Hillard M.
    Bredeson, Christopher N.
    Olsson, Richard
    Saber, Wael
    Aljurf, Mahmoud D.
    Artz, Andrew S.
    McCarthy, Philip L.
    Cooke, Kenneth R.
    Ho, Vincent T.
    Pasquini, Marcelo C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S45 - S46
  • [4] Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Rodriguez, Tulio E.
    Hari, Parameswaran
    Stiff, Patrick J.
    Smith, Scott E.
    Sterrenberg, Danielle
    Vesole, David H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (08) : 1391 - 1396
  • [5] Role of palifermin for autologous hematopoietic stem cell transplantation after conditioning with high-dose melphalan
    Verraes, Kristof
    Delforge, Michel
    ACTA CLINICA BELGICA, 2010, 65 (06): : 457 - 457
  • [6] HIGH-DOSE BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN PRIOR TO TRANSPLANTATION
    MARIT, G
    CONY, P
    DAVID, B
    BROUSTET, A
    REIFFERS, J
    BONE MARROW TRANSPLANTATION, 1988, 3 : 78 - 78
  • [7] High-dose idarubicin and busulphan as conditioning regimen to autologous stem cell transplantation in acute myeloid leukemia
    Ferrara, F
    Palmieri, S
    Annunziata, M
    Copia, C
    Pollio, F
    Mele, G
    BONE MARROW TRANSPLANTATION, 2002, 29 : S75 - S75
  • [8] High-dose idarubicin and busulphan as conditioning regimen to autologous stem cell transplantation in acute myeloid leukaemia
    Ferrara, F
    Palmieri, S
    De Simone, M
    D'Amico, MR
    Fasanaro, A
    Viola, A
    Annunziata, M
    Mele, G
    BONE MARROW TRANSPLANTATION, 2004, 33 : S233 - S233
  • [9] BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Veeraputhiran, Muthu
    Jain, Tania
    Deol, Abhinav
    Ayash, Lois
    Kim, Seongho
    Dyson, Gregory
    Bhutani, Divaya
    Lum, Lawrence G.
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    Abidi, Muneer H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (09): : 531 - 535
  • [10] Incidence and mortality of pulmonary aspergillosis after high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
    Fetscher, S
    Potthoff, K
    Technau, K
    Mertens, R
    Waller, CF
    Finke, J
    Mertelsmann, R
    Lange, W
    BLOOD, 1996, 88 (10) : 1658 - 1658